Investor Stock List
Ranked #4,679 of 8,699 institutional investors

Acorn Capital Advisors, LLC

New York, NY

$332M
US stock portfolio at live prices · today −$649K (−0.20%)
Live prices, last trade 11:18 AM ET
Value at quarter end (Q3 2026)
$364M
Change from Q2 2026
−$2.5M (−0.68%)
Positions
17 · 2 new, 0 sold out
Filed
Nov 16, 2026

Not counted in the ranking: none$87.6M of holdings we could not match to a US listing are included at their reported quarter-end value.

Holdings

Q3 2026 13F, live prices
CGON 28.0%PBYI 8.87%TRVI 8.71%CADL 5.49%JBIO 4.59%
StockSharesValue, live% of portfoliovs Q2 2026
CGON CG Oncology, Inc.1,131,500$92.9M28.0%Unchanged
PBYI Puma Biotechnology, Inc.4,131,299$29.4M8.87%Unchanged
TRVI Trevi Therapeutics, Inc.2,144,844$28.9M8.71%Unchanged
CADL Candel Therapeutics, Inc.3,497,948$18.2M5.49%Unchanged
JBIO Jade Biosciences, Inc.986,760$15.2M4.59%Unchanged
VSTM Verastem, Inc.1,469,153$9.8M2.95%Unchanged
OKUR OnKure Therapeutics, Inc.2,839,674$7.9M2.37%Unchanged
AURA Aura Biosciences, Inc.1,025,349$7.1M2.13%Added +10%
ENGN enGene Therapeutics Inc.3,811,782$6.8M2.04%Added +200%
ANTX AN2 Therapeutics, Inc.1,300,000$6.8M2.04%New
BCAX Bicara Therapeutics Inc.668,381$6.0M1.82%Added +4%
TARA Protara Therapeutics, Inc.1,752,115$4.0M1.20%Unchanged
ANNX Annexon, Inc.1,136,974$3.7M1.12%New
WHWK Whitehawk Therapeutics, Inc.932,139$2.9M0.87%Reduced −18%
LONA LeonaBio, Inc.1,144,416$2.7M0.80%Added +80%
QTTB Q32 Bio Inc.216,171$1.9M0.56%Unchanged
KPTIQ Karyopharm Therapeutics Inc.1,222,019$42K<0.1%Reduced −20%